Ocelot Bio
ID: 12981779Peptide therapeutic to treat complications of end-stage liver disease
1
Funding Rounds
$36.0m
Money raised
Recent Funding Rounds
Overview
Peptide therapeutic to treat complications of end-stage liver disease
- Website:
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company Ocelot Bio has raised a total of $36m in funding over 1 rounds.
Key Insights:
- Ocelot Bio Series A round, March 23, 2022: $36m
Industries
Ocelot Bio is active in the following industries: